Asociación entre el tiempo de uso de fistula arteriovenosa en pacientes con enfermedad renal crónica y la tasa de éxito en el manejo endovascular

dc.contributor.advisorVargas Pérez, Oliverio
dc.contributor.advisorUribe Capputi, Juan Carlos
dc.contributor.apolounabVargas Pérez, Oliverio [oliverio-vargas-pérez]spa
dc.contributor.authorRosales Rueda, Sergio Andrés
dc.contributor.cvlacVargas Pérez, Oliverio [0001765288]spa
dc.contributor.orcidVargas Pérez, Oliverio [0000-0003-3389-711X]spa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.spatialBucaramanga (Santander, Colombia)spa
dc.coverage.temporal2018-2023spa
dc.date.accessioned2024-02-21T16:46:34Z
dc.date.available2024-02-21T16:46:34Z
dc.date.issued2024-02-01
dc.degree.nameEspecialistas en Radiología e Imágenes Diagnósticasspa
dc.description.abstractLa prevalencia de la enfermedad renal crónica (ERC) ha venido en aumento a nivel mundial por lo que la población en hemodiálisis de mantenimiento también se está expandiendo. Las FAV son el acceso vascular “estándar de oro” para el tratamiento de hemodiálisis crónica debido a los menores riesgos de complicaciones asociadas con el uso a largo plazo en comparación con los injertos arteriovenosos. El estado funcional de la fístula arteriovenosa afecta directamente la eficiencia de la diálisis y la calidad de vida de los pacientes urémicos. Hasta 50 % de las fístulas pierden la permeabilidad durante el curso del tratamiento, y en la actualidad lla Angioplastia transluminal percutánea (ATP) se ha recomendado como tratamiento de primera línea para la estenosis y la oclusión del acceso vascular porque es segura, eficaz y mínimamente invasiva en comparación con la revisión quirúrgica En consecuencia, determinamos las tasas de permeabilidad postintervención y los factores que contribuyen al fracaso de la fístula después de la intervención para establecer la permeabilidad secundaria en pacientes con enfermedad renal crónica avanzada que presentaban síntomas de disfunción de la misma.spa
dc.description.abstractenglishThe prevalence of chronic kidney disease (CKD) has been increasing worldwide, so the population on maintenance hemodialysis is also expanding. AVFs are the “gold standard” vascular access for chronic hemodialysis treatment due to the lower risks of complications associated with long-term use compared to arteriovenous grafts. The functional status of the arteriovenous fistula directly affects the efficiency of dialysis and the quality of life of uremic patients. Up to 50% of fistulas lose patency during the course of treatment, and percutaneous transluminal angioplasty (PTA) has now been recommended as a first-line treatment for vascular access stenosis and occlusion because it is safe, effective, and minimally invasive compared to surgical revision Accordingly, we determined postintervention patency rates and factors contributing to fistula failure after intervention to establish secondary patency in patients with advanced chronic kidney disease who presented with symptoms of fistula dysfunction.spa
dc.description.degreelevelEspecializaciónspa
dc.description.learningmodalityModalidad Presencialspa
dc.description.tableofcontents1. INTRODUCCIÓN 5 2. DESCRIPCIÓN DEL PROBLEMA 7 2.1 JUSTIFICACIÓN 7 3. MARCO TEÓRICO 9 3.1 CONTEXTO ENFERMEDAD RENAL CRÓNICA 9 3.2 ANATOMÍA Y FISIOLOGÍA DE FAV 9 3.3 FRACASO PRIMARIO DE LA FÍSTULA ARTERIOVENOSA 11 3.4 PREDICTORES DE FALLA PRIMARIA 12 3.5 PREVENCIÓN DE LA FALLA PRIMARIA DE LA FÍSTULA 13 3.6 MANEJO DE FALLA PRIMARIA 14 3.7 ESTENOSIS DEL ACCESO ARTERIOVENOSO ( VENA PERIFÉRICA) 15 3.8 TROMBOSIS DE ACCESO ARTERIOVENOSO 17 4. ESTADO DEL ARTE 21 5. OBJETIVOS 23 6. METODOLOGÍA 24 7. ALMACENAMIENTO ELECTRÓNICO DE LA INFORMACIÓN 26 8. DISPOSICIONES VIGENTES. 27 8.1 CONSIDERACIONES ÉTICAS. 27 8.2 PROTECCIÓN DE DATOS PERSONALES. 28 9. RECURSOS HUMANOS, MATERIALES Y FINANCIEROS 29 RECURSOS HUMANOS: 29 RECURSOS MATERIALES: 29 RECURSOS FINANCIEROS: 29 10. RESULTADOS 30 10.1 CARACTERÍSTICAS GENERALES DE LOS PACIENTES ESTUDIADOS 30 10.2 CARACTERÍSTICAS CLÍNICAS 30 10.3 CARACTERÍSTICAS RELACIONADAS CON LAS FISTULAS ARTERIOVENOSAS 31 10.4 RELACIONADAS CON LA INTERVENCIÓN 33 10.5 ANÁLISIS BIVARIADO 34 11. DISCUSIÓN 43 12. CONCLUSIÓN 47 13. BIBLIOGRAFÍA 48 ANEXOS 53 ANEXO 1. Tabla 1. Variables del estudio 53spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/23569
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programEspecialización en Radiología e Imágenes Diagnósticasspa
dc.publisher.programidERAD-272
dc.relation.references1. Almasri J, Alsawas M, Mainou M, Mustafa RA, Wang Z, Woo K, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg 2016;64:236e43.spa
dc.relation.references2. Leermakers JJ, Bode AS, Vaidya A, van der Sande FM, Evers SM, Tordoir JH. Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts. Eur J Vasc Endovasc Surg 2013;45:84e92.spa
dc.relation.references3. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006;17:3204e12.spa
dc.relation.references4. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008;299:2164e71.spa
dc.relation.references5. Masengu A, Maxwell AP, Hanko JB. Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort. Clin Kidney J 2016;9:142e7.spa
dc.relation.references6. Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P. Biology of arteriovenous fistula failure. J Nephrol. 2007;20(2):150-163spa
dc.relation.references7. Maya ID, Oser R, Saddekni S, Barker J, Allon M. Vascular access stenosis: comparison of arteriovenous grafts and fistulas. Am J Kidney Dis. 2004;44(5):859-865spa
dc.relation.references8. Turmel-Rodrigues L, Mouton A, Birmele B, Billaux L, Ammar N, Grézard O.Salvage of immature forearm fistulas for haemodialysis by interventional radiology. Nephrol Dial Transplant 2001; 16: 2365-71spa
dc.relation.references9. Modi GK, Jha V. The incidence of end-stage renal disease in India: A population-based study. Kidney Int 2006;70:2131-3spa
dc.relation.references10. Quencer KB, Arici M. Arteriovenous fistulas and their characteristic sites of stenosis. Am J Roentgenol 2015;205:726-34.spa
dc.relation.references11. Stoumpos S, Traynor JP, Metcalfe W, Kasthuri R, Stevenson K, Mark PB, et al. A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population. J Vasc Surg 2019;69:1889-98spa
dc.relation.references12. National Kidney Foundation KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015;66:884-930. 10.1053/j.ajkd.2015.07.015spa
dc.relation.references13. Balamuthusamy S, Reddi AL, Madhrira MH, et al. Clinical predictors of recurrent stenosis and need for re-intervention in the cephalic arch in patients with brachiocephalic AV fistulas. J Vasc Access 2017;18:319-24spa
dc.relation.references14. Malka KT, Flahive J, Csizinscky A, et al. Results of repeated percutaneous interventions on failing arteriovenous fistulas and grafts and factors affecting outcomes. J Vasc Surg 2016;63:772-7. 10.1016/j.jvs.2015.09.031spa
dc.relation.references15. Suemitsu K, Shiraki T, Iida O, et al. Impact of Lesion Morphology on Durability After Angioplasty of Failed Arteriovenous Fistulas in Hemodialysis Patients. J Endovasc Ther 2018;25:649-54. 10.1177/1526602817748316spa
dc.relation.references16. Heye S, Maleux G, Vaninbroukx J, et al. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. Eur J Radiol 2012;81:2298-303. 10.1016/j.ejrad.2011.09.004spa
dc.relation.references17. Elramah M, Boujelbane L, Yevzlin AS, et al. Dialysis access venous stenosis: treatment with balloon angioplasty 30-second vs. 1-minute inflation times. Hemodial Int 2015;19:108-14. 10.1111/hdi.12183spa
dc.relation.references18. Higashiura W, Takara H, Kitamura R, et al. Factors Associated with Secondary Functional Patency After Percutaneous Transluminal Angioplasty of the Early Failing or Immature Hemodialysis Arteriovenous Fistula. Cardiovasc Intervent Radiol 2019;42:34-40. 10.1007/s00270-018-2083-0spa
dc.relation.references19. Lozano RN (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128spa
dc.relation.referencesVascular Access Group (2006) Clinical practice guidelinesfor vascular access. Am J Kidney Dis 48:248–273.spa
dc.relation.referencesAl-Jaishi A, Oliver M, Thomas S, Lok C et al (2014) Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 6(3):464–478spa
dc.relation.references22. Oliver MJ. The Science of Fistula Maturation. J Am Soc Nephrol. 2018 Nov;29(11):2607-2609.spa
dc.relation.references23. Dember LM, Imrey PB, Beck GJ, et al. Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis. 2014;63(1):104-112.spa
dc.relation.references24. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164-2171spa
dc.relation.references25. Al-Jaishi AA, Oliver MJ, Thomas SM, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(3):464-478spa
dc.relation.references26. Palmer SC, Di Micco L, Razavian M, et al. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis. Am J Kidney Dis. 2013;61(1):112-122spa
dc.relation.references27. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204-3212.spa
dc.relation.references28. Ene-Iordache B, Cattaneo L, Dubini G, Remuzzi A. Effect of anastomosis angle on the localization of disturbed flow in “side-to-end” fistulae for haemodialysis access. Nephrol Dial Transplant. 2013;28(4):997-1005.spa
dc.relation.references29. MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, Miller LM; Canadian Society of Nephrology Vascular Access Work Group. Arteriovenous Access Failure, Stenosis, and Thrombosis. Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669126spa
dc.relation.references30. McLafferty RB, Pryor RW, III, Johnson CM, Ramsey DE, Hodgson KJ. Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vasc Surg. 2007;45(5):981-985spa
dc.relation.references31. Allon M, Robbin ML, Young CJ, et al. Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes. Clin J Am Soc Nephrol. 2013;8(10):1750-1755spa
dc.relation.references32. Beathard GA, Arnold P, Jackson J, Litchfield T; Physician Operators Forum of RMSL. Aggressive treatment of early fistula failure. Kidney Int. 2003;64(4):1487-1494.spa
dc.relation.references33. Riella MC, Roy-Chaudhury P. Vascular access in haemodialysis: strengthening the Achilles’ heel. Nat Rev Nephrol. 2013;9(6):348-357spa
dc.relation.references34. Chang CJ, Ko PJ, Hsu LA, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43(1):74-84.spa
dc.relation.referencesMaya ID, Oser R, Saddekni S, Barker J, Allon M. Vascular access stenosis: comparison of arteriovenous grafts and fistulas. Am J Kidney Dis. 2004;44(5):859-865.spa
dc.relation.references36. Ram SJ, Work J, Caldito GC, Eason JM, Pervez A, Paulson WD. A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int. 2003;64(1):272-280.spa
dc.relation.references37. Beathard GA, Litchfield T; Physician Operators Forum of Rms Lifeline I. Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int. 2004;66(4):1622-1632.spa
dc.relation.references38. Kariya S, Tanigawa N, Kojima H, et al. Primary patency with cutting and conventional balloon angioplasty for different types of hemodialysis access stenosis. Radiology. 2007;243(2):578-587.spa
dc.relation.referencesKatsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19(2):263-272spa
dc.relation.referencesShah A, Ansari N, Hamadeh Z. Cardiac arrest secondary to bilateral pulmonary emboli following arteriovenous fistula thrombectomy: a case report with review of the literature. Case Rep Nephrol. 2012;2012:831726spa
dc.relation.references41. Lee T, Barker J, Allon M. Needle infiltration of arteriovenous fistulae in hemodialysis: risk factors and consequences. Am J Kidney Dis. 2006;47(6):1020-1026.spa
dc.relation.references42. Ponikvar R, Premru V, Kersnic B. Surgical thrombectomy of thrombosed arteriovenous grafts by interventional nephrologists. Ther Apher Dial. 2011;15(3):306-310.spa
dc.relation.references43. Schon D, Mishler R. Pharmacomechanical thrombolysis of natural vein fistulas: reduced dose of TPA and long-term follow-up. Semin Dial. 2003;16(3):272-275.spa
dc.relation.references44. Davidson CJ, Newman GE, Sheikh KH, Kisslo K, Stack RS, Schwab SJ. Mechanisms of angioplasty in haemodialysis fistula stenoses evaluated by intravascular ultrasound. Kidney Int 1991; 40: 91-5spa
dc.relation.references45. Sands J, Young S, Miranda C. The effect of Doppler flow screening studies and elective revisions on dialysis access failure. ASAIO J 1992; 38: M524-7 46. Tan TL, May KK, Robless PA, Ho P. Outcomes of endovascular interventionspa
dc.relation.references46. Tan TL, May KK, Robless PA, Ho P. Outcomes of endovascular intervention for salvage of failing hemodialysis access. Ann Vasc Dis. 2011;4(2):87-92spa
dc.relation.references47. Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, Roy-Chaudhury P. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol. 2011 Mar;6(3):575-81spa
dc.relation.referencesManou-Stathopoulou S, Robinson EJ, Harvey JJ, Karunanithy N, Calder F, Robson MG. Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: A retrospective cohort. J Vasc Access. 2019 Nov;20(6):716-724.spa
dc.relation.references49. https://repository.unab.edu.co/handle/20.500.12749/41spa
dc.relation.references50. US Renal Data System 2017 USRDS Annual Data Report: executive summaryAm J Kidney Dis, 71 (3 suppl 1) (2018), pp. S1-S8spa
dc.relation.references51. O. Yoshihiro, I. Hirotoshi, and T. Shoichi, “A damp-and-push technique for the copolymer (onyx) embolization of dural arteriovenous fistula,” Journal of Stroke and Cerebrovascular Diseases, vol. 30, no. 8, pp. 566–569, 2021spa
dc.relation.references52. Asif, P. Roy-Chaudhury, G.A. Beathard Early arteriovenous fistula failure: a logical proposal for when and how to intervene Clin J Am Soc Nephrol, 1 (2) (2006), pp. 332-339.spa
dc.relation.references53. M. Yoshiki, I. Satoshi, and T. Eisuke, “A rare brainstem hemorrhage due to incomplete transvenous embolization of the cavernous sinus dural arteriovenous fistula: a case report,” Radiology Case Reports, vol. 16, no. 9, pp. 67–73, 2021.spa
dc.relation.references54. M. Priti, B. Vinant, and S. Sumit, “Stretching the boundaries: suitability of an arteriovenous fistula in elderly patients on hemodialysis-a northern India experience,” International urology and nephrology, vol. 55, no. 52, pp. 58–64, 2021.spa
dc.relation.references55. N. Hayato, F. Hiroki, and N. Takaaki, “Adjuvant heparinization before manipulation of artery reduces early failure in primary arteriovenous fistula for end-stage renal disease patients,” Clinical and experimental nephrology, vol. 25, no. 12, pp. 677–679, 2021.spa
dc.relation.references56. Suryawanshi M, Dutta P, Ganduboina R, Rajput V, Pawar SG. Standardization of Pre-operative Evaluation to Improve the Outcome of Arteriovenous Fistula for Vascular Access of Hemodialysis: A Review of 700 Cases. Cureus. 2023 Sep 26;15(9):e45999.spa
dc.relation.references57. MHuber TS, Berceli SA, Scali ST, Neal D, Anderson EM, Allon M, Cheung AK, Dember LM, Himmelfarb J, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Imrey PB, Beck GJ, Farber AM, Kaufman JS, Kraiss LW, Vongpatanasin W, Kusek JW, Feldman HI. Arteriovenous Fistula Maturation, Functional Patency, and Intervention Rates. JAMA Surg. 2021 Dec 1;156(12):1111-1118spa
dc.relation.references58. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, et al. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011;6(8):1996–2002.spa
dc.relation.references59. Corea Cho S. The feasibility of surgical salvage of thrombosed arteriovenous fistula by an interventional nephrologist. Kidney Res Clin Pract. 2017;36(2):175–81spa
dc.relation.references60. Prasad N, Thammishetti V, Bhadauria DS, Anupama K, Sharma RK, Srivastava A, et al. Outcomes of radiocephalic fistula created by nephrologists. J Vasc Access. 2019;20(6):615–20,spa
dc.relation.references61. Hod T, Desilva RN, Patibandla BK, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Factors predicting failure of AV “fistula first” policy in the elderly. Hemodial Int. 2014;18(2):507–15.spa
dc.relation.references62. Ramanan SV, Prabhu RA, Rao IR, Chawla A, Shenoy SV, Nagaraju SP, et al. Outcomes and predictors of failure of arteriovenous fistulae for hemodialysis. Int Urol Nephrol. 2022;54:185–92.spa
dc.relation.references63. Hod T, Desilva RN, Patibandla BK, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Factors predicting failure of AV “fistula first” policy in the elderly. Hemodial Int. 2014;18(2):507– Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int. 2003;63(1):346–52.spa
dc.relation.references64. Venkatnarayanan R, Dogra PM, Bavdekar R, Singh SK, Mondal AK. Primary failure of Autogenous Arteriovenous Fistula: critical analysis. Indian J Nephrol. 2020;30(6):382–90.spa
dc.relation.references65. Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg. 2007;45(2):420–6.spa
dc.relation.references66. M. Monroy-Cuadros, S. Yilmaz, A. Salazar-Banuelos, C. DoigRisk factors associated with patency loss of hemodialysis vascular access within 6 monthsClin J Am Soc Nephrol, 5 (10) (2010), pp. 1787-1792.spa
dc.relation.references67. G. Pawan, K. Pushpinder, and P. Preetham, “Iatrogenic preauricular arteriovenous fistula in underlying slow-flow venous malformation and its endovascular management,” Indian Journal of Vascular and Endovascular Surgery, vol. 8, no. 3, pp. 188–192, 2021spa
dc.relation.references68. 67. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112–1127, 2006spa
dc.relation.referencesNguyen B, Duong MC, Diem Tran HN, Do KQ, Nguyen KTT. Arteriovenous fistula creation by nephrologist and its outcomes: a prospective cohort study from Vietnam. BMC Nephrol. 2023 Apr 4;24(1):88spa
dc.relation.references70. So YH, Choi YH, Oh S, Jung IM. Thrombosed native hemodialysis fistulas : Technical and clinical outcomes of endovascular recanalization and. 2019;spa
dc.relation.uriapolohttps://apolo.unab.edu.co/en/persons/oliverio-vargas-p%C3%A9rezspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.keywordsMedical sciencesspa
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsRadiologyspa
dc.subject.keywordsDiagnostic imagingspa
dc.subject.keywordsArteriovenous fistulaspa
dc.subject.keywordsChronic kidney diseasespa
dc.subject.keywordsPercutaneous transluminal angioplastyspa
dc.subject.keywordsEndovascular treatmentspa
dc.subject.keywordsRenal diseasesspa
dc.subject.keywordsBlood vesselsspa
dc.subject.keywordsArteriovenous anastomosisspa
dc.subject.lembCiencias médicasspa
dc.subject.lembRadiologíaspa
dc.subject.lembDiagnóstico para imágenesspa
dc.subject.lembEnfermedades renalesspa
dc.subject.lembVasos sanguíneosspa
dc.subject.lembAnastomosis arteriovenosaspa
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalFistula arteriovenosaspa
dc.subject.proposalEnfermedad renal crónicaspa
dc.subject.proposalAngioplastia transluminal percutaneaspa
dc.subject.proposalTratamiento endovascularspa
dc.titleAsociación entre el tiempo de uso de fistula arteriovenosa en pacientes con enfermedad renal crónica y la tasa de éxito en el manejo endovascularspa
dc.title.translatedAssociation between the time of arteriovenous fistula use in patients with chronic kidney disease and the success rate of endovascular managementspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM

Archivos

Bloque original

Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
Tesis.pdf
Tamaño:
908.53 KB
Formato:
Adobe Portable Document Format
Descripción:
Tesis
Cargando...
Miniatura
Nombre:
Licencia.pdf
Tamaño:
279.31 KB
Formato:
Adobe Portable Document Format
Descripción:
Licencia

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
829 B
Formato:
Item-specific license agreed upon to submission
Descripción: